Introduction: Simulator sickness causes vestibulo-autonomic responses that increase sympathetic activity and decrease parasympathetic activity. The purpose of the study was to quantify these responses through electrogastrography and cardiac interbeat intervals during fl ight simulation. Methods: There were 29 subjects that were randomly assigned to 2 parallel arms: 1) oculovestibular recoupling, where galvanic vestibular stimulation was synchronous with the visual fi eld; and 2) control. Electrogastrography and interbeat interval data were collected during baseline, simulation, and post-simulation periods. A simulator sickness questionnaire was administered. Results: Statistically signifi cant differences were observed in percentage of recording time with the dominant frequency of electrogastrography in normogastric and bradygastric domains between the oculovestibular recoupling and control groups. Normogastria was dominant during simulation in the oculovestibular recoupling group. In the control group, the percentage of recording time with the dominant frequency decreased by 22% in normogastria and increased by 20% in bradygastria. The percentage change of the dominant power instability coeffi cient from baseline to simulation was 26% in the oculovestibular recoupling group vs. 108% in the control group. The power of high-frequency components for interbeat intervals did not change signifi cantly in the oculovestibular recoupling group and was decreased during simulation in the control group. Discussion: Electrogastrography and interbeat intervals are sensitive indices of autonomic changes in subjects undergoing fl ight simulation. These data demonstrate the potential of oculovestibular recoupling to stabilize gastric activity and cardiac autonomic changes altered during simulator and motion sickness.
LECTROGASTROGRAPHY (EGG) has been advocated as a diagnostic test for clinical evaluation of patients with unexplained nausea, vomiting, and other dyspeptic symptoms. In aerospace medicine, EGG has been a reliable and objective measurement of abnormal gastric activity related to motion sickness (MS) and simulator sickness (SS), a visually generated or computergenerated form of MS ( 25 ) . Changes in gastric myoelectric activity were also demonstrated during the fi rst few days of spacefl ights, when gastric dysrhythmia was concomitant with episodes of nausea and vomiting ( 8 ) .
Gastric myoelectrical activity can be recorded noninvasively by EGG, enabling accurate measurement of gastric waves, which are typically identifi ed by their slow frequency and low amplitude (100 m V to 500 m V).
The dominant frequency (DF) of EGG at 0.05 Hz or 3 cycles per minute (cpm) corresponds to the basic electrical rhythm (BER). The BER refl ects the myoelectric activity of the stomach smooth muscle that originates from the pacemaker region in the upper half of the gastric body along the greater curvature. This pacemaker consists of interstitial cells of Cajal that are regulated by autonomic nerves. Increased vagal (parasympathetic) activity augments gastric motility, whereas increased sympathetic activity or vagal withdrawal decreases gastric motility ( 8 ) . Disturbances of the BER (i.e., gastric dysrhythmia) have been described in disorders of delayed gastric emptying, postoperative nausea or vomiting, MS and other gastrointestinal disorders, and failure of autonomic neural regulation ( 12 ) . Gastric dysrhythmia has three different patterns: 1) tachygastria, which is increased DF (3 cpm to 4-9 cpm regular activity); 2) bradygastria, which is decreased DF (3 cpm to 1-2 cpm regular activity); and 3) tachyarrhythmia, which consists of a series of premature control potentials followed fi rst by a compensatory pause and then by irregular activity (4-9 cpm) ( 4 ) .
The fi rst use of EGG evaluation of circularvectioninduced MS (onset, time-course, and symptoms) was reported by Stern and colleagues ( 27 ) , who induced circularvection by rotating an optokinetic drum around the subject ' s spinal axis. They reported a shift in DF from 3 cpm to one of 5 cpm to 8 cpm (tachygastria) in all symptomatic subjects (67%). In 64% of these subjects, the tachygastria preceded MS symptoms by 1 min, and returned to the 3-cpm BER within 1 to 9 min after discontinuation of the visual stimulus.
EGG has also been used to evaluate the effi cacy of certain pharmacologic interventions. Stern et al. ( 28 ) used OVR SIMULATION -CEVETTE ET AL.
the EGG analysis to demonstrate that phenytoin prevents the degradation of the normal rhythmic 3-cpm gastric signal to a dysrhythmic signal of 4 cpm to 9 cpm in subjects exposed to MS, when compared with placebo.
During SS, the visual-vestibular mismatch causes vestibulo-autonomic responses that lead to increased sympathetic nervous system activity and decreased parasympathetic nervous system activity ( 26 ) . This leads, in turn, to gastric tachyarrhythmia, with subsequently increased vagal and splanchnic afferent activity resulting in nausea and simultaneous release of vasopressin ( 26 , 30 ) . The activation of vestibulo-autonomic responses results in changes in heart rate variability (HRV), skin conductance, and respiratory rate, which have all been demonstrated during MS along with EGG changes ( 14 , 19 , 22 ) . However, the correlation between EGG measures and subjective ratings of MS has been varied ( 10 , 24 ) . Tachygastria has been reported both in symptomatic subjects and in asymptomatic subjects ( 9 ) . This variation in previously reported fi ndings might be due to the use of different stimulation methods, the lack of standardized methodology (e.g., electrode placement, recording periods, test meals), or different analytic software and reference values ( 3 , 4 ) .
Over the past decade, EGG became popular in clinical medicine because of the rapid advances in computer science and biomedical engineering that led to the development of amplifi ers, fi ltering of noise and movement artifacts, and spectral analysis. EGG has been used to quantify the effect of galvanic vestibular stimulation (GVS) in mitigating the gastrointestinal and vestibular symptoms induced by caloric stimulation ( 23 ) . However, to the best of our knowledge, no studies have evaluated the role of EGG in quantifying the effect of GVS in mitigating SS. We recently showed that the implementation of GVS in a visual fl ight simulator [oculovestibularrecoupled (OVR) stimulation] minimizes the intersensory confl ict that is thought to provoke symptoms such as nausea, vomiting, and dizziness ( 2 ) . Therefore, the aims of the current study were: 1) to quantify EGG responses in two groups of subjects during fl ight simulation with or without OVR; 2) to correlate EGG responses with subjective reporting of SS with or without OVR; and 3) to correlate vestibulo-autonomic [cardiac interbeat interval (IBI) or HRV] responses with subjective reporting of SS with or without OVR.
METHODS

Subjects
There were 29 subjects (18 men and 11 women; median age, 27.1 yr [range, 18-38 yr] ) who enrolled in a randomized trial approved by the Mayo Clinic Institutional Review Board. Recruitment focused on subjects with no history of MS, vestibular disorders, or gastrointestinal disease. A negative urine pregnancy test was required for female participants. Informed consent was obtained from all subjects prior to enrollment.
Equipment
Illusory self-motion (vection) was created by exposing the subjects to 20 min of a prerecorded session of fl ight simulation (X-Plane 9; Laminar Research). The video consisted of a fi rst-person perspective view of an F-22 Raptor fl ight over mountains, with balanced combination of pitch, yaw, and roll performed by an experienced fi ghter pilot. The altitude of the simulated fl ight was maintained between 1000-2000 ft to create a strong vection from the natural surroundings, including trees, mountain peaks, and lakes.
GVS was integrated in the simulator program to combine visual and vestibular stimulation (OVR simulation) [for technical details, see Cevette et al. ( 2 )]. Visual input was then projected onto a 180° cylindrical screen in front of the subject. Electrogastrophic data were recorded with a portable EGG recorder (Medical Measurement Systems, Dover, NH) with low and high cutoff frequencies of 1 and 15 cpm, respectively. The signals were amplifi ed, digitized at a rate of 1 Hz, and transferred to a personal computer for further analysis by a commercially available software program (MATLAB R2011a, Natick, MA). IBIs were continuously measured from peak-to-peak blood pressure recordings using a portable, noninvasive monitor (BMEYE Nexfi n, Amsterdam, The Netherlands) through a sensor cuff around the fi nger.
Procedures
Subjects were asked to consume a light breakfast at least 1 h before the study was started. The experiment was carried out in a quiet, temperature-controlled, lowambient light room in the Aerospace Medicine and Vestibular Research Laboratory, Mayo Clinic, Scottsdale, AZ. Before the simulation session was started, the subjects were randomly assigned to two parallel arms: 1) the OVR group; and 2) the control group. Each subject was tested in only one arm. For the OVR group, a maximum stimulation of 2.5 mA per electrode pair was administered synchronously, along with visual stimulation throughout the test. For the control group, a tactor device was applied to the mastoid electrodes to produce a mild cutaneous sensation of vibration without any resulting motion perception. For the OVR group, four active 20-mm diameter disposable silver/silver chloride gel electrodes (Viasys; CareFusion Corp., San Diego, CA) were placed on the upper mastoid (electrode 1 on the left; electrode 3 on the right), forehead (electrode 2), and nape of the neck (electrode 4). A fi fth electrode was affi xed to the lower nape of the neck as a reference electrode. For the control group, only two electrodes were positioned on the mastoid and connected with the tactor devices.
All subjects had six cutaneous electrodes (Ambu Blue Sensor N; Ambu A/S, Ballerup, Denmark) positioned on the abdomen to record gastric myoelectric signals. The fi rst electrode was positioned below the left rib margin 2 cm from the xiphoid process; the third electrode was placed equidistant between the xiphoid process and the umbilicus; the second and fourth electrodes were placed, respectively, along the left and the right midclavicular lines, 3 cm below the rib margin and equidistant from the midline; the fi fth and sixth electrodes were placed, respectively, along the left and the right midclavicular lines, equidistant from the midline and 3 cm below the line of the second and fourth electrodes. A seventh electrode served as a reference electrode and was placed on the center of the left clavicle. Before each electrode was attached, the skin beneath it was abraded gently to decrease electrical impedance. An elastic band was secured around the chest to detect the respiratory rate. After the electrodes were positioned, each subject was seated in the fl ight simulator and instructed to limit body movements. The experiment was then started and included the following three consecutive periods: 1) a 10-min baseline period during which the subject sat quietly in the simulator chair with eyes closed; 2) a 20-min fl ight simulation with or without OVR; and 3) a 10-min post-simulation period (recovery time) during which the subject remained seated quietly in the simulator chair with eyes closed. The total duration of the experiment was 40 min.
A modifi ed standardized simulator sickness questionnaire was administered to all subjects immediately after completion of the session ( 13 ). The questionnaire included a self-report checklist of 15 symptoms (5 gastrointestinal: salivation, nausea, stomach awareness, burping, and vomiting; 7 central: drowsiness, dizziness, fatigue, headache, blurred vision, diffi culty focusing, and diffi culty concentrating; and 3 peripheral: warmth, sweating, and general discomfort) for subjective rating on a 10-point Likert scale, with higher numbers indicating greater symptom intensity.
EGG data analysis:
The differential bipolar signals were derived from the combinations of the six unipolar electrode channels. From the independent combinations, the differential signal between electrodes 1 and 4 (EGG1-EGG4) was selected for further analysis because of their optimum location on the abdomen and the quality of the data they generated compared to that generated by the other electrode pairs. These signals were digitally fi ltered by applying high-pass and low-pass second-order Butterworth fi lters at 0.01 Hz and 0.16 Hz, respectively, to eliminate artifacts occurring as a consequence of respiration and movement. A fast Fourier transform was then applied on consecutive 64-s EGG segments with a 32-s (50%) overlap with the previous one. Given our analysis parameters, the resulting spectral resolution was slightly under 1 cpm (0.9375 cpm). The fast Fourier transform analyzes complex EGG waveforms and provides a power spectrum of the signal that indicates the relative strengths of various frequency components in normogastric (2 -4 cpm), bradygastric (1 -2 cpm), and tachygastric (4 -9 cpm) ranges. The data obtained by applying the fast Fourier transform provided information on both frequency and amplitude of the EGG signal. In this article, the following computed EGG parameters that are of clinical signifi cance were analyzed.
Percentage of recording time with the dominant EGG frequency: The percentage of recording time with the dominant frequency (DF%) in normogastric, bradygastric, and tachygastric frequency ranges was calculated during three specifi c periods: baseline, simulation, and post-simulation.
Percentage distribution of EGG spectral power (PSP):
The power in each of the normogastric (2 -4 cpm), bradygastric (1 -2 cpm), and tachygastric frequency ranges (4 -9 cpm) was computed during baseline, simulation, and post-simulation periods by summing the powers of the frequencies within respective frequency ranges. The PSP values for each range were calculated by dividing the power in each frequency range by the total power in a range of 1 to 9 cpm.
Instability factors for the dominant power: The stability of the power of the dominant frequency is expressed as the dominant power instability coeffi cient (DPIC). It was computed by dividing the SD of the dominant frequency powers during baseline, simulation, and post-simulation periods by the mean of the dominant frequency powers during each time interval.
IBI data analysis: The IBI [also commonly known as the R-R interval (in milliseconds)] was derived from continuous-pulse pressure waveforms that can be considered a feasible alternative to traditional IBI derived from ECG ( 1 ). In the frequency domain, the fast Fourier transform was applied on consecutive 64-s IBI segments with a 32-s (50%) overlap with the previous one in order to estimate spectral power in low frequency (LF, 0.04-0.15 Hz) and high frequency (HF, 0.15-0.4 Hz) spectral components. Given our analysis parameters, the resulting spectral resolution was 0.015 Hz.
Statistical Analysis
The EGG parameter (DPIC ) and IBI parameter were compared across both groups (OVR vs. control) during baseline, simulation, and post-simulation periods using a two-way mixed model ANOVA followed by the point estimate analysis. DF% in normogastric, bradygastric, and tachygastric ranges during each period were compared between two groups using one-way analysis of variance (ANOVA) followed by the point estimate analysis.
The percentage distribution of EGG spectral power (PSP) in normogastric, bradygastric, and tachygastric ranges was analyzed only through point estimates between periods. Furthermore, IBI and the power of the high frequency (HF) spectral components of IBI were compared between periods in each group by using repeated-measures ANOVA. The correlation of reported symptoms during simulation to the DPIC as well as HF components of IBI was also analyzed. Statistical signifi cance was set at P , 0.05. The results are represented as mean (SD).
RESULTS
All 29 subjects participating in the study completed the experiment. However, data from two subjects (one from each group) were discarded because of low signal-to-noise ratio in the EGG observed during analysis. There were no signifi cant differences in incidence and severity of SS symptoms between the OVR and control groups. The OVR SIMULATION -CEVETTE ET AL.
mean score for all symptoms was less than 2 on a 10-point Likert scale. The highest rating score was for drowsiness (2.9 in the OVR group vs. 3.5 in the control group).
Visual Analysis of EGG Signals
The gastric activity of the subjects during the baseline, simulation, and post-simulation periods can be represented concisely through running spectral analysis, a classical method based on the fast Fourier transform. As shown in Fig. 1 , running spectral analysis represents the EGG data in terms of frequency and its power over the course of the entire experimental time. The relative power change in the three frequency ranges (normogastric, bradygastric, and tachygastric) can be observed visually as the subject goes through the simulation. Fig. 1 compares the gastric activity in two individuals, one in Fig. 1 . The running spectra of the electrogastrography for the entire simulation experiment: A) control subject, and B) oculovestibular recoupling (OVR) subject during the baseline, simulation, and post-simulation periods. range decreased 22% from the baseline to simulation compared to the 4% increase (i.e., almost constant) in the OVR group. In the OVR group, the DF% in the normogastric range during the simulation and post-simulation periods rarely deviated from the baseline. Conversely, in the control group, the DF% in the normogastric range remained 17% below baseline at the end of the postsimulation recovery period. In addition, as shown in Fig. 2B , the DF% in the bradygastric range during the simulation period also had a statistically signifi cant difference between the OVR and Control groups (F (1,25) 5 6.31, P 5 0.02; one-way ANOVA). Based on the point estimate analysis, a signifi cant 20% increase was observed in the DF% in the bradygastric range from baseline to simulation in the control group compared to a 3% increase in the OVR group. No group differences in DF% were noted in the tachygastric range. Fig. 3 shows the PSP in each of the EGG frequency ranges in the baseline, simulation, and post-simulation periods. In the control group, PSP in the normogastric range decreased from baseline by 16% during simulation around the 14 th or 15 th minute of simulation. However, in the OVR group, PSP in the normogastric range never decreased more than 4% from baseline through simulation ( Fig. 3A ) .
Percentage Distribution of EGG Spectral Power
In the control group, the onset of dysrhythmia (indicated by increased PSP in the bradygastric range) began approximately 3 min into the simulation period and continued through minute 12. In the OVR group, the onset of dysrhythmia was delayed until approximately minute 9 of the simulation period. In both groups, the PSP in the bradygastric range decreased after the 12 th minute of simulation and returned to baseline levels by the end of the simulation period (20 th minute) ( Fig. 3B ) . PSP in the tachygastric range increased in both groups after the 12 th minute of simulation ( Fig. 3C ) . By the end of the 20-min simulation period, PSP in the tachygastric range in the control group remained elevated over baseline by 15% compared to a minimal change of 1.5% in the OVR group.
Instability Factors for the Dominant Power
The Generalized Estimating Equations approach introduced by Liang and Zeger ( 16 ) was used to evaluate DPIC using a two-way, mixed-model repeated measures design (2 Group 3 3 Periods) with a fi rst order autoregressive within-subject correlation matrix and gamma distribution with log a link function. The main effect for Group was not statistically signifi cant between OVR and Control [mean (95% CI) 5 0.430 (0.367, 0.504) vs. 0.512 (0.427, 0.613) P 5 0.158]. The main effect for Periods showed a statistically signifi cant linear increase from the baseline period to the simulation period ( P , 0.001). A signifi cant interaction effect was found for Group x Periods [Wald Chi-Square (2 df) 5 6.197; P 5 0.045]. The DPIC was similar between OVR and Control groups at baseline and post-simulation, but DPIC increased each group (control and OVR) during simulation. Fig. 1A (control subject) shows an increase in the spectral power in the bradygastric frequency range (1 -2 cpm) during the simulation period (10 th minute to 30 th minute) that illustrates the gastric dysrhythmia associated with the nausea that accompanies SS. In contrast, Fig. 1B (OVR subject) shows the effect of GVS on mitigating SS during the simulation period with minimal change in the bradygastric frequency range and the dominance of normogastric activity (2 -4 cpm) throughout the experiment. Fig. 2 shows the DF% in the normogastric (part A) and bradygastric (part B) frequency ranges in the baseline, simulation, and post-simulation periods. As shown in Fig. 2A , the DF% in the normogastric range during the simulation period had a statistically signifi cant difference between the OVR and Control groups (F (1,25 ) 5 5.02, P 5 0.03, one-way ANOVA). Based on the point estimate analysis, the control group DF% in the normogastric substantially more in the Control group compared with the OVR group during the simulation period (mean difference 5 -0.269, 95% CI -0.541, 0.004); however, the observed difference failed to reach statistical signifi cance ( P 5 0.053). Furthermore, based on the point estimate analysis, the percentage change of DPIC values from baseline to simulation was 108% (i.e., just over double) in the control group compared to 26% in the OVR group ( Fig. 4 ) . No signifi cant correlation was found between DPIC and sum of the scores of all reported symptoms during simulation (control: R 5 0.1, P 5 0.73; OVR: R 5 0.2, P 5 0.5). units in the plot and as normalized units as the text in mean (SD) format. These data should be reported in both types of units for ease of interpretation because a shift in sympathovagal balance can occur in SS without significant changes in total power. This balance can be assessed by the relation between HF and LF components of normalized units (i.e., relative value of each power component in proportion to the total power; e.g., normalized unit of HF component is represented as HF/(LF+HF) * 100) ( 18 ) . In the control group, the absolute power of the HF components was signifi cantly decreased from baseline to minute 5 of simulation (F (1,12) 5 5.89, P 5 0.03; repeatedmeasures ANOVA); to minute 15 of simulation (F (1,12) 5 8.62, P 5 0.01); and to minute 20 of simulation (F (1,12) 5 7.07, P 5 0.02). There was no signifi cant difference in the absolute power of HF components between the baseline values and the post-simulation values in the control group; however, a signifi cant difference was observed when normalized units were evaluated (F (1,12) 5 4.51, P 5 0.05). In the OVR group, the 20-min simulation did not result in any signifi cant changes in HF components of IBI. This observation suggests that the simulation without OVR suppressed parasympathetic activity (i.e., decreased the power of HF components), with a resultant increase in the dominance of LF components from 47.2% at baseline to 51.8% at the end of the 20-min simulation (F (1,12) 5 7.27, P 5 0.02). No signifi cant correlation was found between the HF components of IBI and sum of the scores of all reported symptoms during simulation (Control: R 5 0.17, P 5 0.56; OVR: R 5 0.01, P 5 0.96).
Percentage of Recording Time with the Dominant EGG Frequency
IBI Analysis
DISCUSSION
Despite the misleading name, SS is a normal psychophysiological response of healthy individuals to apparent motion simulation of signifi cant intensity and/or duration ( 19 ) . SS is better defi ned as a multidimensional subjective syndrome that includes heterogeneous symptoms [gastrointestinal, central, and peripheral ( 7 )] and whose measures are complicated by intersubject variability, severity ratings, and differences in incidence. Therefore, the quantifi cation and comparative analysis of SS results are often arduous. In this scenario, EGG and cardiac autonomic responses have proven to be promising tools for objectively quantifying changes related to simulation.
Tachygastria has been considered synonymous with MS and SS ever since Stern and colleagues ( 27 , 28 ) fi rst reported a shift in the DF of gastric myoelectric activity from 3 cpm to 5 to 8 cpm during circularvection. However, the association between tachygastria and symptoms evoked by motion and vection stimuli has been controversial. Tachygastria does not consistently occur with symptoms of MS, and more importantly, episodes of tachygastria have been observed in asymptomatic subjects during simulation ( 4 ). Tian et al. ( 29 ) reported that bradygastria and normogastria were related to nausea in 81 pilots exposed to Coriolis stimulation. For this reason, other authors prefer to use the term ' dysrhythmia, ' which is defi ned as the absence of normal (2 -4 cpm) slow waves during the observation period, as a more comprehensive index of gastric myoelectric activity disruption resulting from real or induced motion perception ( 17 ) .
Our fi ndings did not show a predominance of tachygastric DF during simulation but did indicate a disruption of gastric activity toward the bradygastric level for the control group ( Fig. 1A ) . These results were indeed expected given the low incidence of major symptoms. Moreover, the incidence and severity of SS symptoms between the OVR and control groups did not differ signifi cantly. These results may have several explanations. First, we induced vection by exposing subjects to a virtual reality video (prerecorded fl ight simulation), whereas in earlier studies, MS was elicited by a rotating optokinetic drum. Second, technical factors, such as inadequate width of fi eld of view, length and/or speed of simulation, fi delity of virtual scenes, and adaptation may have been infl uential ( 11 , 14 ) . Third, the length of exposure to the stimulus might have infl uenced symptoms. Fourth, as previously reported ( 20 ), the time and type of meal consumed before exposure to the simulation might have infl uenced the susceptibility of subjects to develop SS.
Norfl eet et al. ( 21 ) found similar incongruity while comparing the effects of scopolamine and placebo in subjects exposed to MS. Although the scopolaminetreated subjects had signifi cantly fewer episodes of vomiting than did placebo-treated subjects, the difference in subjectively reported symptoms was not significantly different. Norfl eet et al. ( 21 ) speculated that the subjective reporting of MS symptoms was biased both by subjects being reluctant to admit to having any symptoms and by subjects neglecting to mention less distressing symptoms. OVR SIMULATION -CEVETTE ET AL.
Despite the absence of severe symptoms between the two groups (OVR and control) in the present study, the signifi cant differences in EGG recordings might be the result of an early presymptomatic phase of gastric arrhythmia that precedes the onset of the tachygastria commonly associated with MS symptoms. The onset of tachygastric PSP illustrated in Fig. 3C was triggered at minute 12 of simulation and continued to increase ( 9 ) also reported gastric motility changes preceding the sensation of nausea in subjects exposed to a movie with oscillation pictures. Based on animal studies, Fukuda and colleagues ( 6 ) fi rst proposed a model where the activation of a prodromal sign center for vomiting may elicit gastric changes before the sensation of nausea. If the center is strongly activated, the sensation of nausea may be produced in the cortex.
Our results also showed a statistically signifi cant difference in the DF% of the normogastric ( P 5 0.03) and bradygastric ( P 5 0.02) domains between the OVR and the control groups during the simulation period. In the control group, DF% in normogastria decreased by 22% from baseline to simulation and DF% in bradygastria increased by 20% from baseline to simulation. Conversely, in the OVR group, a predominance of normal (2 -4 cpm) gastric slow waves (normal gastric myoelectric activity) was observed during the entire simulation period. These results show that the combined visual-vestibular stimulation in the OVR group may have led to a minimization of the intersensory confl ict that can provoke SS. These fi ndings are consistent with previous studies where the potential role of transcutaneous electrical stimulation in mitigating MS was investigated. Park et al. ( 23 ) found that cathodal galvanic stimulation applied at the mastoid ipsilateral to the irrigated vestibular system during caloric stimulation was able to restore a normal level of gastric motility by reducing the tachygastria induced by the caloric test. Moreover, with the recovery of gastric motility, galvanic stimulation could ameliorate symptoms such as nausea, vomiting, dizziness, and nystagmus ( 23 ). Chu et al. ( 5 ) reported that applying transcutaneous electrical nerve stimulation to the midline posterior nuchal region and the Zusanli acupoint (anterior tibia) signifi cantly reduced MS symptoms induced by Coriolis stimulation. They also reported that transcutaneous electrical nerve stimulation affected the vestibuloautonomic components of HRV during MS, resulting in elevated sympathetic activity and suppressed parasympathetic activity. Similar results have been reported by Lacount et al. ( 15 ) , who investigated the response of the HF components of the HRV to MS. Their results showed a gradual decrease in HF power in response to nausea, as a result of decreased vagal tone (parasympathetic activity) and increased sympathetic activity during MS. Ohyama et al. ( 22 ) focused on the LF components of the HRV during visually induced MS and reported an increase in LF without signifi cant changes in HF. Authors concluded that since LF is infl uenced by both sympathetic and parasympathetic activity, whereas HF is solely infl uenced by parasympathetic activity, an increase in LF without a decrease in HF is the result of sympathetic arousal during MS ( 22 ) .
Our results show that the absolute HF power did not change signifi cantly during the 20-min simulation in the OVR group, whereas in the control group it was decreased from baseline at simulation minute 5, minute 15, and minute 20. This observation suggests that simulation without OVR suppresses parasympathetic activity (i.e., results in decreased HF power), with a resultant increase in the dominance of LF power (from 47.2% at baseline to 51.8% at the end of the simulation).
Our fi ndings indicate that electrogastrography and heart rate variability measures are sensitive indices of autonomic changes in subjects exposed to fl ight simulation that may not correlate directly with subjective reports of SS. These fi ndings suggest that autonomic changes might have their onset in the presymptomatic phase of SS. Therefore, it might be appropriate to monitor them to identify early signs of symptom onset in SS or MS. In addition to more subjective measurements, the quantifi cation of objective autonomic changes could play a major role in the assessment of SS and MS. This study has also shown that OVR technology may have the potential to stabilize the gastric myoelectrical activity and the cardiac autonomic changes commonly associated with SS and MS. More studies involving subjects highly sensitive to MS exposed to more provocative stimuli are required in order to further investigate OVR technology in preventing and/or mitigating SS and MS.
